vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $49.0M, roughly 1.9× Quipt Home Medical Corp.). Quipt Home Medical Corp. runs the higher net margin — -2.1% vs -98.1%, a 95.9% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 32.3%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.

HIVE vs QIPT — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.9× larger
HIVE
$93.1M
$49.0M
QIPT
Growing faster (revenue YoY)
HIVE
HIVE
+186.3% gap
HIVE
218.6%
32.3%
QIPT
Higher net margin
QIPT
QIPT
95.9% more per $
QIPT
-2.1%
-98.1%
HIVE

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
HIVE
HIVE
QIPT
QIPT
Revenue
$93.1M
$49.0M
Net Profit
$-91.3M
$-1.1M
Gross Margin
-27.1%
53.5%
Operating Margin
2.1%
Net Margin
-98.1%
-2.1%
Revenue YoY
218.6%
32.3%
Net Profit YoY
-234.0%
2.9%
EPS (diluted)
$-0.38
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
QIPT
QIPT
Q4 25
$93.1M
$49.0M
Q3 25
$87.3M
$39.8M
Q2 25
$45.6M
$35.1M
Q1 25
$33.3M
Q4 24
$29.2M
$37.1M
Q3 24
$22.6M
Q2 24
$32.2M
Q4 23
$22.8M
Net Profit
HIVE
HIVE
QIPT
QIPT
Q4 25
$-91.3M
$-1.1M
Q3 25
$-15.8M
$-3.5M
Q2 25
$35.0M
$-3.0M
Q1 25
$-3.0M
Q4 24
$68.2M
$-1.1M
Q3 24
$80.0K
Q2 24
$-18.3M
Q4 23
$-24.5M
Gross Margin
HIVE
HIVE
QIPT
QIPT
Q4 25
-27.1%
53.5%
Q3 25
4.7%
48.7%
Q2 25
-13.6%
57.6%
Q1 25
54.6%
Q4 24
-43.7%
52.1%
Q3 24
-66.1%
Q2 24
-7.4%
Q4 23
-52.3%
Operating Margin
HIVE
HIVE
QIPT
QIPT
Q4 25
2.1%
Q3 25
-3.6%
Q2 25
-5.2%
Q1 25
-3.0%
Q4 24
1.2%
Q3 24
Q2 24
Q4 23
Net Margin
HIVE
HIVE
QIPT
QIPT
Q4 25
-98.1%
-2.1%
Q3 25
-18.1%
-8.9%
Q2 25
76.8%
-8.6%
Q1 25
-9.1%
Q4 24
233.2%
-2.9%
Q3 24
0.4%
Q2 24
-56.7%
Q4 23
-107.8%
EPS (diluted)
HIVE
HIVE
QIPT
QIPT
Q4 25
$-0.38
$-0.02
Q3 25
$-0.07
$-0.07
Q2 25
$0.18
$-0.07
Q1 25
$-0.07
Q4 24
$0.52
$-0.03
Q3 24
$0.00
Q2 24
$-0.17
Q4 23
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
QIPT
QIPT
Cash + ST InvestmentsLiquidity on hand
$10.5M
Total DebtLower is stronger
$84.0M
Stockholders' EquityBook value
$559.3M
$113.0M
Total Assets
$624.0M
$280.7M
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
QIPT
QIPT
Q4 25
$10.5M
Q3 25
$12.9M
Q2 25
$11.3M
Q1 25
$17.1M
Q4 24
$40.5M
$15.5M
Q3 24
$31.7M
Q2 24
Q4 23
$4.5M
Total Debt
HIVE
HIVE
QIPT
QIPT
Q4 25
$84.0M
Q3 25
$87.6M
Q2 25
$66.0M
Q1 25
$71.5M
Q4 24
$70.6M
Q3 24
Q2 24
Q4 23
Stockholders' Equity
HIVE
HIVE
QIPT
QIPT
Q4 25
$559.3M
$113.0M
Q3 25
$624.6M
$112.1M
Q2 25
$560.5M
$102.5M
Q1 25
$103.6M
Q4 24
$430.9M
$106.3M
Q3 24
$275.5M
Q2 24
$268.6M
Q4 23
$122.9M
Total Assets
HIVE
HIVE
QIPT
QIPT
Q4 25
$624.0M
$280.7M
Q3 25
$693.0M
$283.3M
Q2 25
$628.7M
$236.1M
Q1 25
$244.6M
Q4 24
$478.6M
$242.8M
Q3 24
$334.7M
Q2 24
Q4 23
Debt / Equity
HIVE
HIVE
QIPT
QIPT
Q4 25
0.74×
Q3 25
0.78×
Q2 25
0.64×
Q1 25
0.69×
Q4 24
0.66×
Q3 24
Q2 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
QIPT
QIPT
Operating Cash FlowLast quarter
$46.0M
$8.9M
Free Cash FlowOCF − Capex
$6.9M
FCF MarginFCF / Revenue
14.0%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$26.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
QIPT
QIPT
Q4 25
$46.0M
$8.9M
Q3 25
$-10.6M
$9.8M
Q2 25
$10.2M
$9.7M
Q1 25
$8.9M
Q4 24
$-28.5M
$9.3M
Q3 24
$-2.2M
Q2 24
$-4.4M
Q4 23
Free Cash Flow
HIVE
HIVE
QIPT
QIPT
Q4 25
$6.9M
Q3 25
$8.0M
Q2 25
$4.4M
Q1 25
$7.3M
Q4 24
$-55.5M
$5.6M
Q3 24
$-34.7M
Q2 24
Q4 23
FCF Margin
HIVE
HIVE
QIPT
QIPT
Q4 25
14.0%
Q3 25
20.0%
Q2 25
12.6%
Q1 25
22.0%
Q4 24
-189.9%
15.2%
Q3 24
-153.4%
Q2 24
Q4 23
Capex Intensity
HIVE
HIVE
QIPT
QIPT
Q4 25
4.2%
Q3 25
4.6%
Q2 25
14.9%
Q1 25
4.8%
Q4 24
92.5%
9.9%
Q3 24
143.9%
Q2 24
Q4 23
Cash Conversion
HIVE
HIVE
QIPT
QIPT
Q4 25
Q3 25
Q2 25
0.29×
Q1 25
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons